Investigating changes in ownership of substance use disorder treatment centers
Substance use disorder treatment centers and facility ownership changes
This study looks at how buying and selling substance use disorder treatment centers, especially by private equity firms, affects the quality of care and results for people getting help, so we can better understand what this means for those seeking treatment.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-11031969 on NIH RePORTER |
What this research studies
This research examines how changes in ownership of substance use disorder (SUD) treatment centers, particularly those acquired by private equity firms, impact the quality of care and patient outcomes. By analyzing data from 2010 to 2022, the study aims to identify trends in treatment accessibility and effectiveness following ownership changes. The research employs a quasi-experimental design to compare patient outcomes before and after these acquisitions, providing insights into the implications for individuals seeking treatment for substance use disorders.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals aged 21 and older who are seeking treatment for substance use disorders.
Not a fit: Patients who are not seeking treatment for substance use disorders or those who are outside the age range of 21 and older may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding of how ownership changes affect the quality of substance use disorder treatment, ultimately enhancing care for patients.
How similar studies have performed: Previous research has indicated that ownership changes in healthcare facilities can impact quality of care, suggesting that this study's approach is grounded in established findings.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Busch, Susan H — Yale University
- Study coordinator: Busch, Susan H
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.